A consortium of investigators at the University of California, San Diego with extensive experience in, and a commitment to, clinical research collaborations in the area of asthma, are proposing two multi-center clinical trials for the NIH-sponsored Asthma Clinical Research Network. The UCSD consortium is led by Drs. Stephen Wasserman and Joe Ramsdell. Study 1 will be undertaken in stable steroid dependent asthmatic adults. It will examine the effect of etanercept, an inhibitor of TNF-alpha, in an 18-week, double-blind, placebo-controlled clinical trial in this population. The primary outcome to be evaluated will be the ability of this agent to permit significant reduction in inhaled steroid dosage without exacerbation. Study 2 will also employ a double-blind, placebo-controlled design. This trial will evaluate the ability of CPAP to improve nocturnal asthma, in a population of overweight, adult patients with moderate-to-severe asthma, who also suffer from sleep disordered breathing. Patients for these, and other Network trials, will be recruited from the Medicine, Pulmonary and Allergy clinics of UCSD, the San Diego VA, the San Diego US Naval Hospital, and Kaiser- Permanente. The available population is large, multi-racial and multi-ethnic, reflecting the San Diego environment. We are also proposing an educational program, under the direction of Dr. Andrew Ries, which will utilize the extensive resources available at UCSD.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10HL074218-02
Application #
6800523
Study Section
Special Emphasis Panel (ZHL1-CSR-B (M1))
Program Officer
Ortega, Hector
Project Start
2003-09-15
Project End
2008-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
2
Fiscal Year
2004
Total Cost
$766,032
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Lugogo, Njira; Green, Cynthia L; Agada, Noah et al. (2018) Obesity's effect on asthma extends to diagnostic criteria. J Allergy Clin Immunol 141:1096-1104
Nyenhuis, Sharmilee M; Krishnan, Jerry A; Berry, Alalia et al. (2017) Race is associated with differences in airway inflammation in patients with asthma. J Allergy Clin Immunol 140:257-265.e11
Peters, Stephen P; Bleecker, Eugene R; Kunselman, Susan J et al. (2013) Predictors of response to tiotropium versus salmeterol in asthmatic adults. J Allergy Clin Immunol 132:1068-1074.e1
Calhoun, William J; Ameredes, Bill T; King, Tonya S et al. (2012) Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. JAMA 308:987-97
Sutherland, E Rand; Goleva, Elena; King, Tonya S et al. (2012) Cluster analysis of obesity and asthma phenotypes. PLoS One 7:e36631
McGrath, Kelly Wong; Icitovic, Nikolina; Boushey, Homer A et al. (2012) A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 185:612-9
Szefler, Stanley J; Chinchilli, Vernon M; Israel, Elliot et al. (2012) Key observations from the NHLBI Asthma Clinical Research Network. Thorax 67:450-5
Vora, Chirag; Renvall, Marian J; Chao, Peter et al. (2011) 2007 San Diego wildfires and asthmatics. J Asthma 48:75-8
Peters, Stephen P; Kunselman, Susan J; Icitovic, Nikolina et al. (2010) Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 363:1715-26
Sutherland, E Rand; King, Tonya S; Icitovic, Nikolina et al. (2010) A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol 126:747-53

Showing the most recent 10 out of 14 publications